Home
»
Press Room
»
Neurovascular Devices Market To Reach $11.91Bn By 2033

Neurovascular Devices Market To Reach $11.91 Billion By 2033

February 2026 | Report Format: Electronic (PDF)

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is estimated to reach USD 11.91 billion by 2033, registering a CAGR of 5.40% from 2026 to 2033, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

key Request a free sample copy or view report summary: Neurovascular Devices Market Report

Neurovascular Devices Market Report Highlights

The cerebral embolization and aneurysm coiling devices segment held the largest share in 2025.
The stroke segment held the largest share in 2025. This dominance can be attributed to the growing prevalence of stroke across the globe.
The hospital segment dominated the market in 2025, accounting for the largest share.
North America accounted for the largest share of the neurovascular devices market in 2025.
The neurovascular devices market in the Asia Pacific is expected to register the fastest growth.

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market on the basis of device, application, end use, and region:

Neurovascular Devices Outlook (Revenue USD Million, 2021 - 2033)

Cerebral Embolization and Aneurysm Coiling Devices
- Embolic coils
- Flow diversion devices
- Liquid embolic agents
Cerebral Angioplasty and Stenting Systems
- Carotid artery stents
- Embolic protection systems
Neurothrombectomy Devices
- Clot retrieval devices
- Suction devices/aspiration catheters
- Vascular snares
Support Devices
- By Size
  - 0.027"
  - 0.021"
  - 0.071"
  - 0.017"
  - 0.019"
  - 0.013"
  - 0.058"
  - 0.068"
  - Others
- By Product
  - Micro catheters
  - Micro guidewires
Trans Radial Access Devices